News
From $16.50 to a 9X Run: What This Scan Sees Next
Analyst Sam Gatlin highlights five small AI‑biology stocks tied to Mark Zuckerberg’s Biohub $1.8 billion project, noting one has already crossed his scan’s one‑year‑high trigger. He offers free names of the stocks before they cross, cites past success with Robinhood and Super Micro, and promotes the All Star Charts newsletter.